Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer ; volume:11 ; number:1 ; day:13 ; month:6 ; year:2013 ; pages:1-12 ; date:12.2013
Journal of translational medicine ; 11, Heft 1 (13.6.2013), 1-12, 12.2013
- Creator
-
Lavoué, Vincent
- Contributor
-
Thédrez, Aurélie
Leveque, Jean
Foucher, Fabrice
Henno, Sébastien
Jauffret, Vincent
Belaud-Rotureau, Marc-Antoine
Catros, Veronique
Cabillic, Florian
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-11-147
- URN
-
urn:nbn:de:1111-2016041446691
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lavoué, Vincent
- Thédrez, Aurélie
- Leveque, Jean
- Foucher, Fabrice
- Henno, Sébastien
- Jauffret, Vincent
- Belaud-Rotureau, Marc-Antoine
- Catros, Veronique
- Cabillic, Florian
- SpringerLink (Online service)
Other Objects (12)
Novel paradigm for immunotherapy of ovarian cancer by engaging prophylactic immunity against hepatitis B virus
Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
Ovarian Suppression: Early Menopause and Late Effects
Suppression of GNAI2 message in ovarian cancer
Therapeutic strategies in epithelial ovarian cancer
Surgery for Recurrent Epithelial Ovarian Cancer
Chemotherapy for Advanced Epithelial Ovarian Cancer
Treatment of Recurrent Epithelial Ovarian Cancer
Proteomic landscape of epithelial ovarian cancer
Epithelial Ovarian Cancer: Real-World Outcomes
Immune profile of primary and recurrent epithelial ovarian cancer cases indicates immune suppression, a major cause of progression and relapse of ovarian cancer
Enhancement and suppression in a lexical interference fMRI-paradigm
Novel paradigm for immunotherapy of ovarian cancer by engaging prophylactic immunity against hepatitis B virus
Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
Ovarian Suppression: Early Menopause and Late Effects
Suppression of GNAI2 message in ovarian cancer
Therapeutic strategies in epithelial ovarian cancer
Surgery for Recurrent Epithelial Ovarian Cancer
Chemotherapy for Advanced Epithelial Ovarian Cancer
Treatment of Recurrent Epithelial Ovarian Cancer
Proteomic landscape of epithelial ovarian cancer
Epithelial Ovarian Cancer: Real-World Outcomes
Immune profile of primary and recurrent epithelial ovarian cancer cases indicates immune suppression, a major cause of progression and relapse of ovarian cancer
Enhancement and suppression in a lexical interference fMRI-paradigm
Novel paradigm for immunotherapy of ovarian cancer by engaging prophylactic immunity against hepatitis B virus
Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
Ovarian Suppression: Early Menopause and Late Effects
Suppression of GNAI2 message in ovarian cancer
Therapeutic strategies in epithelial ovarian cancer
Surgery for Recurrent Epithelial Ovarian Cancer
Chemotherapy for Advanced Epithelial Ovarian Cancer
Treatment of Recurrent Epithelial Ovarian Cancer
Proteomic landscape of epithelial ovarian cancer
Epithelial Ovarian Cancer: Real-World Outcomes
Immune profile of primary and recurrent epithelial ovarian cancer cases indicates immune suppression, a major cause of progression and relapse of ovarian cancer